A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results

Eur J Cancer. 1991:27 Suppl 4:S26. doi: 10.1016/0277-5379(91)90561-q.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage
  • Female
  • Humans
  • Hydroxyurea / administration & dosage
  • Interferon Type I / administration & dosage
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Recombinant Proteins

Substances

  • Interferon Type I
  • Recombinant Proteins
  • Cytarabine
  • Hydroxyurea